CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-3/A Offering F-3/A
- POS AM Other Post-effective Amendment for Registration Statement
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- SC 13D/A Stake Beneficial Ownership Report
- UPLOAD Other SEC-generated Letter
- F-3 Offering F-3
- D Other Notice of Sales of Unregistered Securities
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13G/A Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
Page 21 of 38 · 746 filings